(Boursier.com) — The group Intrasense continues its growth by recording a turnover of 1,905 KE. Excluding the war zone, it is up 42% compared to 2021. The group’s strategy of investing, in terms of sales force, in its two key markets, Europe and China, continues to pay off. France recorded a very good performance with business growth of +31%, and the Group recorded growth of +26% in China, thanks to a reorganization of its sales forces intended to better understand market expectations. The geopolitical situation explains the loss of activity in the zone integrating Russia, Belarus and Ukraine.
The signing of a major 8-year commercial contract in Brazil illustrates the first results of a proactive policy of diversification of commercial activities, oriented towards areas with high development potential. Bringing Myrian into compliance with the new European regulation for medical devices, the regulatory submission of which was made in August 2022, will enable the validation of a next version to be obtained in 2023 and will thus be an opportunity to further accelerate the sales.
Human resources: an investment for tomorrow’s growth
Personnel costs amounted to 1,827 KE with an increase of 443 KE, in accordance with the strategy announced by the Group during its capital increase in June 2021. The recruitment of new Marketing and ‘R&D’ talents, dedicated to the development of the new line of products in oncology and the integration of artificial intelligence within Myrian – with new partnerships concluded with Milvue and Nurea this semester – constitutes a sustainable lever of innovation and growth for the Group. The strengthening of the sales team in China and France is bringing very encouraging initial results, in the context of a Chinese market tempted by protectionism and despite the geopolitical difficulties in Ukraine.
External expenses amounted to 843 KE with an increase of 337 KE. This increase is due to the use of outsourced resources, in particular management and transition staff, in order to be able to meet the challenges of skills needs, pending internal recruitment. This increase is also the result of an increase in recruitment costs, always with the objective of sourcing the best talent in a highly competitive job market.
This increase is therefore neither recurrent nor structural and is linked to the group’s current growth period. The restated operating profit before allocations and depreciations (EBITDA) thus amounted to -991 thousand. The group presents an operating loss at the end of the half-year, resulting from the investment policy decided in mid-2021 and managed in a monitored and controlled manner. Availability (cash) remains at a high level and stood at +2,580 KE as of June 30, 2022. They also reflect investment in new talent, intended to support growth.
©2022 Boursier.com